ES8504658A1 - Procedimiento para preparar ibuprofen cristalino - Google Patents

Procedimiento para preparar ibuprofen cristalino

Info

Publication number
ES8504658A1
ES8504658A1 ES530082A ES530082A ES8504658A1 ES 8504658 A1 ES8504658 A1 ES 8504658A1 ES 530082 A ES530082 A ES 530082A ES 530082 A ES530082 A ES 530082A ES 8504658 A1 ES8504658 A1 ES 8504658A1
Authority
ES
Spain
Prior art keywords
ibuprofen
crystals
bulk
crystalline ibuprofen
equant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530082A
Other languages
English (en)
Other versions
ES530082A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ES8504658A1 publication Critical patent/ES8504658A1/es
Publication of ES530082A0 publication Critical patent/ES530082A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR IBUPROFEN CRISTALINO.COMPRENDE: A) FORMAR A UNA TEMPERATURA ENTRE 20J Y 60JC, UNA SOLUCION DE IBUPROFEN EN UN SOLVENTE LIQUIDO, QUE CONTIENE ALREDEDOR DE 10 EN VOLUMEN DE UN SOLVENTE LIQUIDO (BGB H I 8); B) AJUSTAR LA TEMPERATURA DE LA SOLUCION DE IBUPROFEN:SOLVENTE (BGB H I 8), POR ENCIMA DEL PUNTO DE SATURACION, PARA OBTENER UNA SOLUCION COMPLETA DEL CONTENIDO DE IBUPROFEN EN LA MISMA; C) ENFRIAR LA SOLUCION DE IBUPROFEN EN SOLVENTE (BGB H I 8) RESULTANTE, DURANTE 0,5 A 3 HORAS Y A UNA TEMPERATURA ENTRE 0J Y C20JC, PARA CRISTALIZAR Y PRECIPITAR AL IBUPROFEN DE LA SOLUCION DEL MISMO; D) AGITAR LA MEZCLA ENFRIADA DE IBUPROFEN:SOLVENTE (BGB H I 8) PARA OBTENER UN EQUILIBRIO SOLIDO/LIQUIDO EN LA MEZCLA; Y E) SEPARAR EL IBUPROFEN CRISTALINO DEL COMPONENTE LIQUIDO DE LA MEZCLA. EL SOLVENTE (BGB H I 8) SE SELECCIONA ENTRE METANOL, ETANOL Y PROPANOL. SIENDO BGB H PARAMETRO DEL ENLACE DE HIDROGENO EN UNIDADES HILDEBRAND.
ES530082A 1983-02-28 1984-02-27 Procedimiento para preparar ibuprofen cristalino Granted ES530082A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47082083A 1983-02-28 1983-02-28
US06/517,116 US4476248A (en) 1983-02-28 1983-07-25 Crystallization of ibuprofen

Publications (2)

Publication Number Publication Date
ES8504658A1 true ES8504658A1 (es) 1985-05-01
ES530082A0 ES530082A0 (es) 1985-05-01

Family

ID=27043233

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530082A Granted ES530082A0 (es) 1983-02-28 1984-02-27 Procedimiento para preparar ibuprofen cristalino

Country Status (10)

Country Link
US (1) US4476248A (es)
EP (1) EP0120587B1 (es)
JP (1) JPH0623126B2 (es)
KR (1) KR900003298B1 (es)
AU (1) AU567125B2 (es)
CA (1) CA1212693A (es)
DE (1) DE3460098D1 (es)
ES (1) ES530082A0 (es)
MX (1) MX161333A (es)
PH (1) PH20032A (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8606762D0 (en) * 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone
SE463541B (sv) 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
JPH05506011A (ja) * 1990-04-11 1993-09-02 ジ・アップジョン・カンパニー 流動床コーティングによるイブプロフェンの味覚マスキング
US5151551A (en) * 1990-09-06 1992-09-29 Hoechst Celanese Corporation Method for purification of ibuprofen comprising mixtures
EP0558621B1 (en) * 1990-11-19 1995-03-08 Albemarle Corporation Process for improving flow characteristics of crystalline ibuprofen
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5300301A (en) * 1992-12-02 1994-04-05 Hoechst Celanese Corporation Isolation of ibuprofen from tablets
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
GB2315661B (en) * 1996-07-26 2000-05-03 Unilever Plc Frozen food product
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
BR9808009B1 (pt) * 1997-03-14 2009-01-13 processo para a produção de um produto alimentìcio congelado, e, produto congelado.
US5935946A (en) * 1997-07-25 1999-08-10 Gilead Sciences, Inc. Nucleotide analog composition and synthesis method
ZA986614B (en) 1997-07-25 1999-01-27 Gilead Sciences Nucleotide analog composition
FI122018B (fi) * 2000-01-31 2011-07-29 Danisco Menetelmä betaiinin kiteyttämiseksi
HRP20000328A2 (en) * 2000-05-19 2002-02-28 Pliva Farmaceutska Ind Dionik Novel polymorph v of torasemide
DK1389207T3 (da) * 2001-03-01 2006-04-18 Gilead Sciences Inc Polymorfe og andre krystallinske former af cis-FTC
CA2445702A1 (en) * 2001-04-26 2002-11-07 Bristol Myers Squibb Company Control of compactability through crystallization
DE10153934A1 (de) * 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
KR20090053867A (ko) 2003-01-14 2009-05-27 길리애드 사이언시즈, 인코포레이티드 복합 항바이러스 치료를 위한 조성물 및 방법
ES2330321T3 (es) * 2003-05-16 2009-12-09 Cephalon France Procedimiento de sintesis de modafinilo.
FR2857253B1 (fr) * 2003-07-07 2007-02-09 Ethypharm Sa Installation comprenant une machine de fabrication de comprimes en particulier a usage therapeuthique
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
EP1790192A4 (en) 2004-09-09 2010-06-02 Godehard A Guenther SPEAKERS AND SYSTEMS
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
US8189840B2 (en) 2007-05-23 2012-05-29 Soundmatters International, Inc. Loudspeaker and electronic devices incorporating same
US20100222311A1 (en) * 2007-10-19 2010-09-02 Purdue Research Foundation Solid formulations of crystalline compounds
AU2010270976B2 (en) * 2009-06-22 2014-03-20 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ， インコーポレイテッド （Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
JP5821247B2 (ja) * 2010-04-07 2015-11-24 大正製薬株式会社 イブプロフェンの昇華抑制方法
CN102311335B (zh) * 2010-06-29 2013-12-11 山东新华制药股份有限公司 高松密度布洛芬的制备工艺
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
CN102936194A (zh) * 2012-11-14 2013-02-20 陕西合成药业有限公司 一种高纯度的布洛芬的精制方法
CA3002551A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(com pound 1)for use in s1p1 receptor-associated disorders
EP3582814B1 (en) 2017-02-16 2024-05-01 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
CN113200846B (zh) * 2021-04-23 2022-04-22 浙江新和成股份有限公司 一种高松密度布洛芬球形晶体的制备方法及其产品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica
JPS5614654B2 (es) * 1974-04-11 1981-04-06
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4189596A (en) * 1976-05-24 1980-02-19 The Upjohn Company Preparing 2-arylalkanoic acid derivatives

Also Published As

Publication number Publication date
EP0120587B1 (en) 1986-04-23
PH20032A (en) 1986-09-04
CA1212693A (en) 1986-10-14
AU2377184A (en) 1984-09-06
JPS59167536A (ja) 1984-09-21
KR900003298B1 (ko) 1990-05-14
KR840007554A (ko) 1984-12-08
US4476248A (en) 1984-10-09
ES530082A0 (es) 1985-05-01
MX161333A (es) 1990-09-10
AU567125B2 (en) 1987-11-12
DE3460098D1 (en) 1986-05-28
JPH0623126B2 (ja) 1994-03-30
EP0120587A1 (en) 1984-10-03

Similar Documents

Publication Publication Date Title
ES8504658A1 (es) Procedimiento para preparar ibuprofen cristalino
IT1178365B (it) Dispositivo di costipamento del contenuto di cassoni di semi-rimorchio di grande capacita'
MY102396A (en) Detergent granules and a process for their preparation
JPS5633032A (en) Material having water absorbing and water-holding capacity
EP0421702A3 (en) Interfacial purifying apparatus using tourmaline, method thereof and tourmaline granular material
CA2006733A1 (en) Polyimide foam
GR3004434T3 (es)
Oeiestad et al. Study of Growth and Survival of Herring Larvae(Clupea harengus L.) Using Plastic Bag and Concrete Basin Enclosures.
DE2960343D1 (en) Particles made from polylactones derived from polyhydroxy-carboxylic acids and pulverulent compositions containing these particles
EP0284434A3 (en) Method of forming crystals
CA2069255A1 (en) Granules of .alpha.-l-aspartyl-l-phenylalanine methyl ester
BR9500984A (pt) Mistura em pó para preparo de chá gelado de baixa caloria e método para reduzir insolúveis numa bebida de chá gelado de baixa caloria
JPS57123822A (en) Preparation of calcite-type calcium carbonate crystal
JPS5333999A (en) Granulated material of zeolite
Lindholm Variation in Sphagnum shoot numbers and shoot bulk density in hummocks of a raised bog.
AU510281B2 (en) Water soluble product from raw material containing protein and carbohydrate
JPS55151034A (en) Polyurethane foam with water retention
JPS5352280A (en) Powdery aggregation agent
Andoh et al. Shape Memory Effect and Microstructures on Sputter-Deposited Cu--Al--Ni Films
Matsuda et al. Polycrystalline rhombohedral boron nitride and method of producing the same
DE3265836D1 (en) Process for preparing ammoniumnitrate-containing granules of high bulk density
Spohn et al. 1988), top and bottom have been confused in the caption log pm•=-0.0831 ogAv-0.6
JPS5793351A (en) Composite magnetic developer
Semukhin et al. Microstructure of Ni sub 3 Al Produced by Self-Propagating High Temperature Synthesis
JPS5929194U (ja) 氷食品

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20041004